Replies to post #402924 on Amarin Corp Plc (AMRN)

[Pharmacydude]

Golf
“Also don’t you think big pharma with resources could find a way to get US market back with a fixed combo etc and Denner knows that “

NO. Absolutely NO. The FDC will have no purpose in the US market. Insurance companies will refuse to pay for it. The insurance companies will say take the cheapest generic Staten and the cheapest gV. FDC only has a purpose for converting patients to it at the end of the patent life cycle so that when generics enter the European market patients will continue on with the FDC.

Dinner has no secret weapon that will suddenly make insurance companies want to pay for V pay for FDC

[rosemountbomber]

And when did Denner take a stake in the company ?

Before KM started cutting salesforce. Of course if we forward the calendar 6 months, KM presided over the disaster 1Q results because he was way behind in taking care to preserve cash. That is what triggered Denner to ask for board seats and then recommend Abstain at the June AGM.

As far as who convinces BP to grab V and move with it, current management wants the gravy train to continue. Denner wants to sell, make money, and move on. Something we all should have done after R-I label expansion, didn't, but now need to. Anyone think it would be a great thing to have inscribed on my gravestone: He spent most of his life invested in Amarin.?

[golf stud]

To me it’s very simple the US market needs to be in play. I have heard many posters ask why isn’t amarin pursuing this or that. I get it it probably is because of cash issues.

Fine then set yourself up to be sold to a big pharma that has the cash to pursue these indications to get the US market back

Convince the big pharma what they have and they will pay

Who does this current management or Denner?